136 related articles for article (PubMed ID: 10347560)
41. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
[TBL] [Abstract][Full Text] [Related]
42. [Acute myeloid leukemia with t (3;8) (q26.2;q24), a simple variant of 3q26.2/EVI1 translocation].
Sato K; Sakai H; Uchida A; Uemura Y; Tsuruoka Y; Yokoi S; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Tomita N; Inoue Y; Miura I
Rinsho Ketsueki; 2017; 58(4):315-322. PubMed ID: 28484159
[TBL] [Abstract][Full Text] [Related]
43. Translocation (1;11)(q23;p15), a novel simple variant of translocation (7;11)(p15;p15), in a patient with AML (M2) accompanied by non-Hodgkin lymphoma and gastric cancer.
Hatano Y; Miura I; Kume M; Miura AB
Cancer Genet Cytogenet; 2000 Feb; 117(1):19-23. PubMed ID: 10700860
[TBL] [Abstract][Full Text] [Related]
44. Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia.
Nagai S; Nannya Y; Takahashi T; Kurokawa M
Ann Hematol; 2010 Jul; 89(7):741-2. PubMed ID: 19904535
[No Abstract] [Full Text] [Related]
45. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases.
Sempere A; Jarque I; Guinot M; Palau J; García R; Sanz GF; Gomis F; Pérez-Sirvent ML; Senent L; Sanz MA
Leuk Lymphoma; 1993 Dec; 12(1-2):103-8. PubMed ID: 8161925
[TBL] [Abstract][Full Text] [Related]
46. 17p- syndrome arising from a novel dicentric translocation in a patient with acute myeloid leukemia.
Watson N; Dunlop L; Robson L; Sharma P; Smith A
Cancer Genet Cytogenet; 2000 Apr; 118(2):159-62. PubMed ID: 10748299
[TBL] [Abstract][Full Text] [Related]
47. Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia.
Nakayama H; Tomizawa D; Tanaka S; Iwamoto S; Shimada A; Saito AM; Yamashita Y; Moritake H; Terui K; Taga T; Matsuo H; Kosaka Y; Koh K; Hosoi H; Kurosawa H; Isoyama K; Horibe K; Mizutani S; Adachi S
Pediatr Int; 2017 Oct; 59(10):1046-1052. PubMed ID: 28771903
[TBL] [Abstract][Full Text] [Related]
48. [Testicular relapse in acute myelogenous leukemia (AML-M2) with t(8;21) chromosome abnormality].
Yashige H; Nishida K; Horiike S; Yokota S; Okamoto Y; Tsuda S; Maekawa T; Misawa S; Abe T; Takino T
Rinsho Ketsueki; 1985 Sep; 26(9):1475-80. PubMed ID: 3866872
[No Abstract] [Full Text] [Related]
49. A new specific chromosomal rearrangement, t(11;20)(p15;q11), in myeloblastic leukemia with maturation.
Mitelman F; Prigogina EL; Fleischman EW; Frenkel MA; Garwicz S; Heim S; Ilyinskaya GW; Kristoffersson U; Mandahl N; Volkova MA
Leukemia; 1988 Jul; 2(7):430-2. PubMed ID: 3164800
[TBL] [Abstract][Full Text] [Related]
50. [Klinefelter syndrome and acute myeloblastic leukaemia].
Bellaaj H; Sandi HS; Kammoun H; Kallel C; Kassar O; Elloumi M
Presse Med; 2009 Jun; 38(6):1019-22. PubMed ID: 19167185
[No Abstract] [Full Text] [Related]
51. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
[TBL] [Abstract][Full Text] [Related]
52. Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype.
Khoury H; Dalal BI; Nevill TJ; Horsman DE; Barnett MJ; Shepherd JD; Toze CL; Conneally EA; Sutherland HJ; Hogge DE; Nantel SH
Leuk Lymphoma; 2003 Oct; 44(10):1713-8. PubMed ID: 14692523
[TBL] [Abstract][Full Text] [Related]
53. Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.
Silva ML; Land MG; Maradei S; Otero L; Veith M; Brito G; Klumb C; Fernandez T; Pombo-de-Oliveira MS
Cancer Genet Cytogenet; 2002 May; 135(1):101-2. PubMed ID: 12072208
[TBL] [Abstract][Full Text] [Related]
54. Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside.
Ghaddar HM; Plunkett W; Kantarjian HM; Pierce S; Freireich EJ; Keating MJ; Estey EH
Leukemia; 1994 Aug; 8(8):1269-74. PubMed ID: 8057660
[TBL] [Abstract][Full Text] [Related]
55. [Successful treatment with idarubicin in a pediatric case of t(8;21) acute myelogenous leukemia with additional chromosomal abnormalities at relapse].
Wakazono Y; Kataoka A; Fusaoka T; Tunamoto K
Rinsho Ketsueki; 1998 Jul; 39(7):499-505. PubMed ID: 9750457
[TBL] [Abstract][Full Text] [Related]
56. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
57. Translocation t(11;19)(q23;q13.1) without MLL Rearrangement in Acute Myeloid Leukemia: Heterogeneity of the 11q23 Breakpoints.
Yamamoto K; Kawamoto S; Kakiuchi S; Yakushijin K; Matsuoka H; Minami H
Acta Haematol; 2015; 134(2):76-9. PubMed ID: 25895667
[No Abstract] [Full Text] [Related]
58. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
59. Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.
Candoni A; Martinelli G; Toffoletti E; Chiarvesio A; Tiribelli M; Malagola M; Piccaluga PP; Michelutti A; Simeone E; Damiani D; Russo D; Fanin R
Leuk Res; 2008 Dec; 32(12):1800-8. PubMed ID: 18621416
[TBL] [Abstract][Full Text] [Related]
60. Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation.
Parovichnikova EN; Loukianova IA; Troitskaya VV; Drokov MY; Lobaova TI; Kuzmina LA; Sokolov AN; Kokhno AV; Fidarova ZT; Baskhaeva GA; Gavrilina OA; Vasilyeva VA; Obukhova TN; Kuznetsova SA; Sudarikov AB; Dvirnik VN; Galtseva IV; Davidiva JO; Kulikov SM; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):14-22. PubMed ID: 30701918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
